• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性阻塞性肺疾病急性加重]

[Acute exacerbation of COPD].

作者信息

Lange C G, Scheuerer B, Zabel P

机构信息

Medizinische Klinik, Forschungszentrum Borstel.

出版信息

Internist (Berl). 2004 May;45(5):527-38. doi: 10.1007/s00108-004-1170-2.

DOI:10.1007/s00108-004-1170-2
PMID:15054575
Abstract

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) often develop into emergency situations that are associated with high morbidity and mortality. There is still a lack of a generally accepted definition for the risk stratification in AECOPD to guide an optimal diagnosis and treatment. In this article we propose a classification based on 4 degrees of severity, depending on whether outpatient treatment can be done by the patient himself or is provided by a physician and whether inpatient treatment is carried out on a general ward or on an intensive care unit. The pharmacological therapy of AECOPD relies on short acting bronchodilators, systemic corticosteroids and in case of purulent sputum on antibiotics. Longacting beta(2)-agonists or anticholinergics, theophyllin, mucolytic drugs or mechanical percussion to the chest by a physiotherapist have no proven value in the emergency treatment of AECOPD. In respiratory failure the use of oxygen therapy and non-invasive positive pressure ventilation (NIPPV) can often prevent the need for endotracheal intubation and controlled mechanical ventilation, thus preventing associated risks like the development of nosocomial pneumonia.

摘要

慢性阻塞性肺疾病急性加重(AECOPD)常常发展为与高发病率和死亡率相关的紧急情况。目前仍缺乏一个被普遍接受的AECOPD风险分层定义来指导最佳诊断和治疗。在本文中,我们提出一种基于4级严重程度的分类方法,这取决于患者是可自行进行门诊治疗还是由医生提供治疗,以及住院治疗是在普通病房还是在重症监护病房进行。AECOPD的药物治疗依赖于短效支气管扩张剂、全身用糖皮质激素,若有脓性痰则使用抗生素。长效β₂受体激动剂或抗胆碱能药物、茶碱、黏液溶解剂或物理治疗师进行的胸部机械叩击在AECOPD的紧急治疗中尚无已证实的价值。在呼吸衰竭时,使用氧疗和无创正压通气(NIPPV)通常可避免气管插管和控制机械通气的需要,从而预防诸如医院获得性肺炎等相关风险。

相似文献

1
[Acute exacerbation of COPD].[慢性阻塞性肺疾病急性加重]
Internist (Berl). 2004 May;45(5):527-38. doi: 10.1007/s00108-004-1170-2.
2
Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.慢性阻塞性肺疾病急性加重:危重症患者的诊断、管理与预防
Pharmacotherapy. 2015 Jun;35(6):631-48. doi: 10.1002/phar.1599. Epub 2015 Jun 1.
3
Acute exacerbations in chronic obstructive pulmonary disease: current strategies with pharmacological therapy.慢性阻塞性肺疾病的急性加重:药物治疗的当前策略
Drugs. 2003;63(14):1481-8. doi: 10.2165/00003495-200363140-00004.
4
Acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重
Emerg Med Clin North Am. 2003 May;21(2):331-52, viii. doi: 10.1016/s0733-8627(03)00014-2.
5
[Acute exacerbations of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重]
Presse Med. 2009 Mar;38(3):485-95. doi: 10.1016/j.lpm.2008.12.014. Epub 2009 Jan 29.
6
The clinical and integrated management of COPD.慢性阻塞性肺疾病的临床与综合管理
Sarcoidosis Vasc Diffuse Lung Dis. 2014 May 12;31 Suppl 1:3-21.
7
Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence.老年人慢性阻塞性肺疾病急性加重的管理:已发表证据的评估
Drugs Aging. 2007;24(4):303-24. doi: 10.2165/00002512-200724040-00004.
8
[Management of acute exacerbations of COPD].[慢性阻塞性肺疾病急性加重的管理]
Rev Mal Respir. 2010 Oct;27(8):939-53. doi: 10.1016/j.rmr.2010.08.003.
9
Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations.非抗生素药物治疗严重慢性阻塞性肺疾病急性加重。
Semin Respir Crit Care Med. 2020 Dec;41(6):842-850. doi: 10.1055/s-0040-1714379. Epub 2020 Jul 29.
10
Management of acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的管理
Pharmacotherapy. 2001 Aug;21(8):929-39. doi: 10.1592/phco.21.11.929.34523.

引用本文的文献

1
[Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: preclinical differential diagnostic and emergency treatment].[支气管哮喘与慢性阻塞性肺疾病急性加重:临床前鉴别诊断与急救治疗]
Anaesthesist. 2009 Jun;58(6):611-22. doi: 10.1007/s00101-009-1536-x.

本文引用的文献

1
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病
Lancet. 2003 Sep 27;362(9389):1053-61. doi: 10.1016/s0140-6736(03)14416-9.
2
[Management of acute exacerbation of chronic obstructive pulmonary disease (COPD)].[慢性阻塞性肺疾病(COPD)急性加重的管理]
Dtsch Med Wochenschr. 2003 Aug 15;128(33):1721-7. doi: 10.1055/s-2003-41341.
3
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.慢性阻塞性肺疾病急性加重住院后的死亡率及与死亡相关的因素。
Chest. 2003 Aug;124(2):459-67. doi: 10.1378/chest.124.2.459.
4
Acute exacerbations in chronic obstructive pulmonary disease: current strategies with pharmacological therapy.慢性阻塞性肺疾病的急性加重:药物治疗的当前策略
Drugs. 2003;63(14):1481-8. doi: 10.2165/00003495-200363140-00004.
5
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis.无创正压通气治疗慢性阻塞性肺疾病急性加重所致呼吸衰竭:Cochrane系统评价与Meta分析
BMJ. 2003 Jan 25;326(7382):185. doi: 10.1136/bmj.326.7382.185.
6
[Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie].
Pneumologie. 2002 Nov;56(11):704-38. doi: 10.1055/s-2002-35553.
7
Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine.慢性阻塞性肺疾病(COPD)患者接种6B型肺炎球菌破伤风类毒素结合疫苗。
Eur Respir J. 2002 Oct;20(4):813-8. doi: 10.1183/09031936.02.00289702.
8
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.新型细菌菌株与慢性阻塞性肺疾病的急性加重
N Engl J Med. 2002 Aug 15;347(7):465-71. doi: 10.1056/NEJMoa012561.
9
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.急性加重期和稳定期慢性阻塞性肺疾病中的呼吸道病毒、症状及炎症标志物
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23. doi: 10.1164/ajrccm.164.9.2105011.
10
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.下呼吸道疾病会促使当前吸烟者的第一秒用力呼气容积(FEV₁)下降,但不会使患有轻度慢性阻塞性肺疾病的既往吸烟者出现这种情况:肺部健康研究的结果
Am J Respir Crit Care Med. 2001 Aug 1;164(3):358-64. doi: 10.1164/ajrccm.164.3.2010017.